Merck | MRK - Selling And Administration Expenses


Merck reported EUR1.57B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Adidas EUR 2.98B 300M Jun/2026
Adyen EUR 90.22M 65.93M Jun/2026
Akzo Nobel EUR 833M 29M Jun/2026
Alcon AG USD 964M 82M Jun/2026
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 18.97M 1.03M Dec/2025
AstraZeneca USD 5.8B 735M Jun/2026
BASF EUR 2.28B 156M Jun/2026
Bayer EUR 3.96B 267M Jun/2026
Beiersdorf EUR 271M 51M Dec/2025
Covestro EUR 445M 8M Dec/2025
Danone EUR 3.14B 1.56B Jun/2026
Fresenius EUR 760M 17M Jun/2026
Fresenius Medical Care EUR 736.01M 12.99M Jun/2026
Genmab DKK 205M 39M Jun/2026
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.19B 75M Jun/2026
GRIFOLS EUR 289M 8M Jun/2026
Henkel EUR 3.5B 13M Jun/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Infineon EUR 433M 54M Jun/2026
Lakefront Biotherapeutics EUR 22.5M 13M Jun/2026
Linde USD 893M 13M Mar/2026
Merck EUR 1.57B 49M Jun/2026
Novartis USD 3.24B 101M Jun/2026
Philips EUR 1.21B 23M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026
UCB EUR 1.47B 193M Dec/2025